Millions of people regularly obtain insufficient sleep 1 . Given the effect of sleep deprivation on our lives, understanding the cellular and molecular pathways affected by sleep deprivation is clearly of social and clinical importance. One of the major effects of sleep deprivation on the brain is to produce memory deficits in learning models that are dependent on the hippocampus 2-5 . Here we have identified a molecular mechanism by which brief sleep deprivation alters hippocampal function. Sleep deprivation selectively impaired 39, 59-cyclic AMP (cAMP)-and protein kinase A (PKA)dependent forms of synaptic plasticity 6 in the mouse hippocampus, reduced cAMP signalling, and increased activity and protein levels of phosphodiesterase 4 (PDE4), an enzyme that degrades cAMP. Treatment of mice with phosphodiesterase inhibitors rescued the sleep-deprivation-induced deficits in cAMP signalling, synaptic plasticity and hippocampus-dependent memory. These findings demonstrate that brief sleep deprivation disrupts hippocampal function by interfering with cAMP signalling through increased PDE4 activity. Thus, drugs that enhance cAMP signalling may provide a new therapeutic approach to counteract the cognitive effects of sleep deprivation.
Millions of people regularly obtain insufficient sleep 1 . Given the effect of sleep deprivation on our lives, understanding the cellular and molecular pathways affected by sleep deprivation is clearly of social and clinical importance. One of the major effects of sleep deprivation on the brain is to produce memory deficits in learning models that are dependent on the hippocampus 2-5 . Here we have identified a molecular mechanism by which brief sleep deprivation alters hippocampal function. Sleep deprivation selectively impaired 39, 59-cyclic AMP (cAMP)-and protein kinase A (PKA)dependent forms of synaptic plasticity 6 in the mouse hippocampus, reduced cAMP signalling, and increased activity and protein levels of phosphodiesterase 4 (PDE4), an enzyme that degrades cAMP. Treatment of mice with phosphodiesterase inhibitors rescued the sleep-deprivation-induced deficits in cAMP signalling, synaptic plasticity and hippocampus-dependent memory. These findings demonstrate that brief sleep deprivation disrupts hippocampal function by interfering with cAMP signalling through increased PDE4 activity. Thus, drugs that enhance cAMP signalling may provide a new therapeutic approach to counteract the cognitive effects of sleep deprivation.
To determine the cellular and molecular mechanisms by which a short 5-h period of sleep deprivation affects hippocampal function 2 , we used in vitro electrophysiological recordings to examine the effects of sleep deprivation on hippocampal long-term potentiation (LTP), a form of synaptic plasticity that relies on molecular mechanisms that are also important for memory consolidation 7 . We examined several forms of NMDA (N-methyl-D-aspartate)-receptor-dependent LTP with different underlying molecular mechanisms to identify molecular targets of sleep deprivation. The long-term maintenance of LTP induced by 4 high-frequency trains of electrical stimuli applied at 5-minute intervals (spaced 4-train stimulation) or by 15 bursts of high-frequency stimuli applied at 5 Hz (theta-burst stimulation, TBS) depends on cAMP, PKA, transcription and translation [8] [9] [10] . Both of these forms of LTP were impaired in hippocampal slices from mice that had been deprived of sleep for 5 h (Fig. 1a, b) . The increased need for sleep that follows brief sleep deprivation dissipates in 1 Neuroscience Graduate Group, 2 Department of Biology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. 3 Neuroscience and Molecular Pharmacology, Wolfson and Davidson Buildings, Faculty of Biomedical and Life Sciences, University of Glasgow, Glasgow G12 8QQ, UK. 4 approximately 2.5 h 11 , and we found that the deficit in spaced 4-train LTP also recovered with 2.5 h of rest after 5 h of sleep deprivation ( Supplementary Fig. 4 ). LTP induction by 4 high-frequency trains of stimuli applied at 5-second intervals (massed 4-train LTP), which produces a stable form of LTP that depends on translation 12 but does not require cAMP/PKA signalling 12, 13 , was unimpaired by sleep deprivation (Fig. 1c ). One-train LTP, a cAMP/PKA-independent form of LTP 6 was also unaffected by sleep deprivation (Fig. 1d ). The lack of an effect of sleep deprivation on massed 4-train LTP and 1-train LTP suggests that brief sleep deprivation does not affect molecular mechanisms that are required for the induction and expression of these forms of LTP, such as NMDA-receptor activation, Ca 21 influx and activation of Ca 21 -calmodulin dependent kinase II (CaMKII) 8, 14, 15 . Because massed 4-train requires translation, the fact that sleep deprivation does not affect this form of LTP suggests that brief sleep deprivation does not generally disrupt translational processes, but instead specifically alters mechanisms that depend upon cAMP/PKA signalling. Whole-cell recordings from area CA1 confirmed that NMDA-receptor function was unaffected by sleep deprivation ( Supplementary Fig. 3 ). These results contrast with studies using longer periods of sleep deprivation, or sleep deprivation that involves exploration of a new environment-both of which affect the initial induction of LTP as well as NMDA-receptor function 4, [16] [17] [18] [19] [20] . We also did not observe any effects of sleep deprivation on basal synaptic properties or short-term plasticity (Supplementary Fig. 2 ), suggesting that the disruption of spaced 4-train and theta-burst LTP is in fact due to disruption of signalling mechanisms underlying these forms of LTP, and not due to non-specific effects on hippocampal function. Because of the role of cAMP signalling in 4-train and theta-burst LTP 8, 13 , we next assessed the effects of sleep deprivation on LTP induced by specific activation of the cAMP pathway using the adenylate cyclase activator forskolin (FSK). The long-term maintenance of LTP induced by FSK treatment (50 mM) was impaired in hippocampal slices from sleep-deprived mice ( Fig. 2a ). Using biochemical assays, we found that baseline cAMP levels were significantly reduced in the CA1 region of hippocampal slices from sleep-deprived mice, as were cAMP levels induced by FSK treatment (Fig. 2c ). These findings demonstrate that sleep deprivation limits the ability of cells within the CA1 region of the hippocampus to respond to adenylate cyclase activation. Using immunohistochemistry, we found that phosphorylation at Ser 133 of CREB, one of the downstream targets of cAMP signalling in the hippocampus 21 , was decreased by sleep deprivation in the CA1 and dentate gyrus regions of the hippocampus (Supplementary Fig. 7 ). Consistent with our published findings that brief sleep deprivation selectively impairs hippocampal function 2 , no effect of sleep deprivation on CREB phosphorylation was observed in the amygdala ( Supplementary Fig. 7 ). This demonstrates that deficient cAMP signalling due to sleep deprivation impairs the activation of at least one major downstream target (CREB) in vivo. Cyclic nucleotide phosphodiesterases (PDEs) are enzymes that provide the sole route for cAMP degradation in cells 22 . We found that co-treatment with 3-isobutyl-1-methylxanthine (IBMX; 30 mM), a broad-spectrum inhibitor of PDEs, rescued FSK-induced LTP as well as cAMP induction in hippocampal slices from sleep-deprived mice (Fig. 2b, c) . These findings demonstrate that reversing deficits in cAMP signalling ameliorates the deficits in FSK-induced LTP, and suggest that PDE activity might be increased by sleep deprivation.
The cAMP-specific PDE4 has a major role in regulating cAMP signalling in the brain 22 . Therefore, we tested whether sleep deprivation increased PDE4 levels and/or activity in the hippocampus. We found that PDE4-specific cAMP breakdown was increased in sleepdeprived mice ( Fig. 3a) , whereas non-PDE4 activity was unaffected LETTERS (sleep-deprived: 50.6 6 2.1 pmol mg 21 min 21 , non-sleep-deprived: 53.4 6 1.9 pmol mg 21 min 21 , P 5 0.33). In mice and humans, PDE4 isoforms are generated by four genes: Pde4a-d 22 . Immunoblotting with a pan-PDE4A antibody showed a trend in sleep-deprived hippocampal tissue towards an increase in a 125-kilodalton (kDa) species, which is of a size expected for the long PDE4A5, PDE4A10 and PDE4A11 isoforms 23 ( Supplementary Fig. 6 ). Probing our hippocampal samples with antisera specific for each of these isoforms showed that PDE4A5 protein was significantly increased by sleep deprivation in the hippocampus, whereas PDE4A10 and PDE4A11 were not detected ( Fig. 3b for PDE4A5; data not shown for null results with PDE4A10 and PDE4A11). Interestingly, transcripts for PDE4A5 are selectively expressed in the brain with highest levels seen in hippocampal areas CA1 and dentate gyrus 24 , the two regions in which reduction in phosphorylated-CREB were observed after sleep deprivation ( Supplementary Fig. 7 ). We also found that sleep deprivation elicited upregulation of Pde4 gene expression, although the pattern of changes was different between transcript and protein levels, suggesting that translation regulation mechanisms may be involved ( Supplementary Fig. 5 ).
To test whether increased PDE4 activity is responsible for deficits in hippocampal function induced by sleep deprivation, we first examined whether the PDE4-selective inhibitor rolipram 22 could rescue deficits in LTP induced by sleep deprivation. Indeed, rolipram treatment (0.1 mM) during spaced 4-train stimulation rescued the maintenance of this form of LTP in slices from sleep-deprived mice. This dose of rolipram had no effect on 4-train LTP in slices from control mice, suggesting that this result was not simply due to a nonspecific enhancement of LTP ( Fig. 3a, b ). To rule out the possibility of a ceiling effect, we assessed the effects of rolipram in slices from sleepdeprived and control mice on 1-train LTP, which is normally a transient form of plasticity. Here, rolipram enhanced the maintenance of 1-train LTP in control mice. However, rolipram had no significant effect in sleep-deprived mice, demonstrating that sleep-deprived mice have a reduced sensitivity to the effects of PDE4 inhibition ( Supplementary Fig. 8 ). These findings suggest that sleep deprivation makes it more difficult to reach the threshold for induction of cAMP/ PKA-dependent LTP, consistent with our observation that sleep deprivation increases the activity of a specific PDE4 isoform that is known to set the threshold for activation when recruited to specific signalling complexes 25 .
We next assessed whether in vivo PDE4 inhibition could prevent impairments in hippocampus-dependent memory consolidation induced by post-training sleep deprivation. Immediately after singletrial contextual fear conditioning, mice were either deprived of sleep by gentle handling for 5 h or left undisturbed in their home cages. Mice received two intraperitoneal injections of either rolipram (1 mg kg 21 ) or vehicle, immediately and 2.5 h after training. The timings of these injections were based on data showing that the effects of rolipram on hippocampal cAMP levels last for about 3 h (personal communication, J. O'Donnell). Memory was assessed using a 5-min retrieval test in the trained context 1 day after conditioning and in an altered context 2 days after conditioning. Context-specific memory, a measure that is particularly dependent on hippocampal function 26 , was measured by subtracting the percentage freezing in the altered context from the percentage freezing in the trained context (see Supplementary Fig. 9 for data from these two tests). Sleep deprivation significantly impaired context-specific memory, and rolipram treatment rescued this deficit (Fig. 4c ). The ability of rolipram to rescue deficits in hippocampusdependent memory produced by sleep deprivation demonstrates that disruption of cAMP signalling is responsible for the effects of sleep deprivation in vivo.
A major challenge in the field of sleep research has been to determine how the sleep disruptions associated with neurological and psychiatric disorders, ageing and everyday living affect cognitive function. The findings presented here define a molecular mechanism underlying the effects of sleep deprivation on hippocampal function at the behavioural and synaptic level ( Supplementary Fig. 1 ), and they lay the groundwork for further analysis of the functional biochemistry of sleep deprivation and the development of new therapeutics to ameliorate the effect of sleep deprivation. These experiments using the PDE4 inhibitor rolipram are the first, to our knowledge, to rescue synaptic plasticity and memory deficits produced by a brief period of sleep deprivation. Our data suggest that if compounds can be developed that block the activity, expression or targeting of the PDE4A5 isoform, they may prove useful in the treatment of the cognitive effects of sleep deprivation. Notably, circadian oscillation of cAMP in the hippocampus has recently been linked to the persistence of memory 27 , so such drugs may also be useful in treating memory deficits associated with alterations in circadian rhythms. It has proven difficult to generate active-site-directed inhibitors showing selectivity for each of the four PDE4 sub-families because of the highly conserved structure of their catalytic unit 25 , but it may be possible to develop compounds that disrupt the targeting of specific PDE4 isoforms from appropriate scaffolds in cells 22, 25 . 30 mM IBMX (in water). Rolipram (0.1 mM in 0.1% DMSO) was applied for 60 min, beginning 30 min before tetanization. cAMP assays on CA1 regions of hippocampal slices 10 min after treatment for 15 min with FSK (50 mM), FSK plus IBMX (30 mM), or vehicle (0.1% ethanol) were performed by radioimmunoassay according to kit instructions. cAMPspecific PDE activity assays 29 and western blots for PDE4A5 (ref. 30 ) were performed as previously described.
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METHODS
Subjects. C57BL/6J adult male mice (2-4 months of age) were housed individually on a 12 h/12 h light/dark schedule with lights on at 7:00 (ZT0). For electrophysiological analysis of NMDA-receptor function, mice were studied at 6 weeks of age. Food and water were available ad libitum throughout the experiment. Each animal was handled daily for 6 days before sleep deprivation. For electrophysiological, biochemical and gene expression experiments, starting at approximately ZT5, mice were sleep-deprived (SD) in their home cages for 5 h by gentle handling 31 . Non-sleep-deprived (NSD) mice were left undisturbed in their home cages. Using electroencephalographic (EEG) and electromyographic (EMG) recordings, we found that this form of sleep deprivation resulted in ,95% wakefulness in SD mice, compared with ,35% wakefulness during the same time period in NSD mice (data not shown). All experiments were approved by the Institution of Animal Care and Use Committee of the University of Pennsylvania, or by the Animal Studies Committee at the University of Toronto, and were carried out in accordance with all National Institutes of Health guidelines. Behaviour. Foreground fear conditioning experiments were performed as previously described 32 . Mice were acclimated to the training/testing room during 6 days of handling. Starting at ZT4-5, mice were placed into the conditioning chamber (Med Associates) and received a 2-s, 1.5-mA scrambled footshock 2.5 min after placement into the chamber. Mice were removed from the chamber 30 s after the shock. For contextual fear conditioning experiments, animals were placed in a new chamber (Med Associates) for 3 min, and received a 2-s, 1.5-mA footshock after 2.5 min. Half of the mice were deprived of sleep as described earlier for 5 h after training. Mice received two intraperitoneal injections of rolipram (1 mg kg 21 ) or vehicle (2% DMSO in 0.9% saline) immediately and 2.5 h after training. For trained context testing, mice received one 5-min exposure to the same conditioned context in the absence of shock 24 h after conditioning. For altered context testing, mice received one 5-min exposure to a new context (another conditioning chamber with smooth flat floor, altered dimensions, and a new odorant), 48 h after conditioning. Conditioning was assayed by measuring freezing behaviour, the complete absence of movement 33 . Freezing was scored during conditioning as well as testing. The behaviour of each mouse was sampled at 5-s intervals, and the percentage of those intervals in which the mouse froze was calculated. Context-specific freezing was calculated by subtracting the freezing level in the altered context from the freezing level in the trained context for each animal. Electrophysiology. Immediately after sleep deprivation, SD and time-matched NSD mice were killed by cervical dislocation, and their hippocampi were dissected rapidly in iced oxygenated artificial cerebrospinal fluid (ACSF). Fieldpotential recordings were carried out as previously reported 32 . In brief, 400 mm thick transverse hippocampal slices were placed in an interface chamber 34 and continuously perfused with oxygenated ACSF while they equilibrated for at least 1.5 h at 30 uC before starting electrophysiological recordings. A bipolar stimulating electrode (A-M systems, Inc.; 0.002 inches diameter nichrome wire) placed in the stratum radiatum was used to elicit action potentials in the Schaffer collateral pathway. An ACSF-filled glass microelectrode (A-M systems, Inc.; 1.5 mm 3 0.85 mm) with a resistance between 0.5 and 3 MV placed in the stratum radiatum region of CA1 was used to record the resulting fEPSPs. Data were acquired using Clampex 8.2 (Axon Instruments, Inc.), and analysed using Clampfit 8.2 (Axon Instruments, Inc.). Peak fEPSP amplitude was required to be at least 3 mV, and stimulus intensity was set to produce 40% of the maximal response. Stimulations occurred every minute, and a 20-min baseline period was recorded in each experiment, and recordings continued for at least 2 h after LTP induction. Initial fEPSP slopes were normalized against the average of the 20 baseline traces.
One-train LTP was induced by a single 100 Hz, 1-s duration train of stimuli. This form of LTP has been shown to be dependent on the NMDA receptor 35 , calcium influx and CaMKII activation, but is independent of PKA or translation 36, 37 . Four-train LTP, an NMDA-receptor-dependent form of LTP 38 consisted of four such trains applied with a 5-min intertrain interval. The long-term maintenance of this form of LTP has a further reliance on cAMP, PKA, transcription and translation 36, 39 . Massed 4-train LTP also used four such trains of stimuli, but with a 5-s intertrain interval. This long-lasting form of LTP, despite being dependent on the NMDA receptor and translation, does not require PKA 38 . TBS consisted of 40-ms duration, 100-Hz bursts delivered at 5 Hz for 3 s (15 bursts of 4 pulses per burst, for a total of 60 pulses). The induction of this form of LTP depends on the NMDA receptor, and its maintenance depends on cAMP 40 . Chemical LTP was induced by treatment of slices for 15 min with 50 mM molecular grade FSK, an adenylate cyclase activator 41 (Sigma-Aldrich) in 0.1% ethanol, or a combination of 50 mM FSK and the broad-spectrum PDE inhibitor 30 mM IBMX 42 (dissolved in water; Tocris Cookson, Inc.). The cAMP-specific PDE4 inhibitor rolipram 43 (Sigma-Aldrich) was applied at 0.1 mM in 0.1% DMSO (Sigma-Aldrich) for 60 min, beginning 30 min before tetanization. In all LTP figures, representative sample sweeps are shown for each LTP experiment. The red sweeps represent the average of the first five baseline sweeps, and the black sweeps represent the last five sweeps in the recording. All scale bars are 5 mV/5 ms.
Input-output characteristics were examined by recording fEPSPs in CA1 resulting from stimuli of increasing intensity. Initial fEPSP slopes were plotted against the corresponding presynaptic fibre volley amplitudes, and the resulting plots were fit with linear regressions. The slope of the maximum elicited fEPSP in each slice was also recorded. Paired-pulse facilitation, a short-term form of synaptic plasticity, was measured in slices from sleep-deprived and control mice. Pairs of stimuli were delivered with varying delays (300, 200, 100, 50 and 25 ms) between the two stimuli, and the initial fEPSP slope from the second stimulus was plotted relative to the slope from the first stimulus.
For whole-cell patch-clamp recordings in slices from SD and NSD mice, coronal brain slices (350 mm) containing the hippocampus were prepared as previously described 44 . Slices were kept in a submerged recovery chamber at room temperature for at least 1 h before electrophysiological experiments, in oxygenated (95% O 2 and 5% CO 2 ) ACSF containing the following (in mM): 124 NaCl, 2.5 KCl, 2 CaCl 2 , 2 MgSO 4 , 25 NaHCO 3 , 1 NaH 2 PO 4 and 10 glucose. Whole-cell patch-clamp recording experiments were performed in a recording chamber on the stage of an Olympus BX51WI microscope with infrared differential interference contrast (DIC) optics for visualization of whole-cell patchclamp recordings. The recording pipettes (3-5 MV) were filled with solution containing (in mM): 102 CsMeSO 3 , 3.7 NaCl, 5 QX-314 chloride, 5 TEA-Cl, 10 BAPTA, 0.2 EGTA, 20 HEPES, 0.3 Mg-ATP and 0.3 Na 3 -GTP (adjusted to pH 7.2 with CsOH). Excitatory postsynaptic currents (EPSCs) were recorded from hippocampal CA1 pyramidal neurons with an Axon 200B amplifier (Molecular Devices), and the stimulations were delivered by a bipolar tungsten stimulating electrode placed in striatum radium. Data were collected and analysed using pClamp 9.2 software. Picrotoxin (100 mM) was always present to block GABA A (c-aminobutyric acid subtype A) receptor-mediated inhibitory synaptic currents. AMPA (a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptor-mediated EPSCs were induced by repetitive stimulations at 0.05 Hz, and neurons were voltage-clamped at 270 mV (liquid junction potential corrected). The NMDA-receptor-mediated EPSCs were recorded in the presence of the AMPA-receptor antagonist 6-cyano-7-nitroquinoxaline-2,3dione (CNQX) (20 mM) and evoked at 0.05 Hz. Neurons were voltage-clamped at 0 mV for the experiments examining the input-output relationship of NMDA-receptor-mediated EPSCs. Data were discarded if access resistance changed by more than 15% during experiments. Biochemistry. For cAMP assays, hippocampal slices were prepared as for electrophysiology, and were treated for 15 min with FSK (50 mM), FSK plus IBMX (30 mM), or vehicle. At 10 min after drug treatment, slices were removed from the rig and the CA1 region was dissected and flash-frozen in a dry-ice and ethanol slurry. Samples were stored at 280 uC until enough had been accumulated to run the assay. For the assay itself, a cAMP-[ 125 I]-radioimmunoassay kit was used (PerkinElmer). Tissue was homogenized on ice in 6% TCA, a set amount (,30,000 c.p.m.) of tritiated cAMP (adenosine 39, 59-cyclic phosphate, ammonium salt, [2, H]; PerkinElmer) was added to each sample, and extracts were centrifuged at 2,500g at 4 uC for 15 min. The pellet was frozen and used later in Bradford assays to determine the total protein concentration in each sample. After extracting the supernatants four times with water-saturated ether, samples were evaporated in a speed-vac and then resuspended in assay buffer. Recovery was assessed by measuring the amount of [ 3 H]-cAMP in each sample using a scintillation counter. The assay was run according to kit instructions for nonacetylated procedure, and the reaction was run at 4 uC overnight. [ 125 I] was measured using a gamma scintillation counter. On the basis of Bradford assays, recovery assessment and standard curves, cAMP levels (pmol mg 21 protein) were calculated for each sample. Because of interassay variability, raw data was normalized for all groups relative to the NSD control average for each assay. Data are therefore presented as percentage NSD control cAMP level.
For PDE activity assays, hippocampi were dissected from SD and NSD mice and immediately frozen in a dry-ice and ethanol slurry. The cAMP-specific PDE activity assay was adapted from the radioassay procedure described previously 45 , as detailed in ref. 46 . In this two-step procedure the samples to be assayed are (in the first step) incubated with 1 mM 8-[ 3 H]-labelled cAMP substrate for 10 min at 30 uC, in the absence or presence of rolipram (10 mm) to determine the rolipraminhibited PDE4 activity. In the second step, the [ 3 H]-labelled cAMP product of cAMP hydrolysis, 59 AMP, was dephosphorylated to adenosine by incubation with 0.2 mg ml 21 snake venom. The negatively charged unhydrolysed cAMP was then separated from the uncharged adenosine by incubation with Dowex ion exchange resin (Dowex-1-chloride); this removes the charged nucleotides but not the uncharged nucleosides. The amount of unbound [ 3 H]-adenosine in the supernatant was determined by scintillation counting to calculate the rate of cAMP hydrolysis. PDE4-specific activity was calculated by subtracting the activity found in the presence of rolipram from the activity in its absence.
For PDE4 western blots, hippocampi were flash-frozen on a dry-ice and ethanol slurry and stored at 280 uC. One-hundred-and-fifty-four micrograms of total protein was resolved using NuPAGE 4-12% Bis-Tris gel and NuPAGE MOPS SDS running buffer (Invitrogen) for 1 h at 190 V. The separated proteins were transferred to nitrocellulose membrane (Protran, Whatman GmbH) for 1 h at 25 V using NuPAGE transfer buffer. The membranes were blocked in 5% marvel/TBST (TBS containing 0.05% (v/v) Tween 20) for at least 1 h with gentle shaking. Antibodies specific for PDE4A, PDE4B, PDE4D, PDE4A5, PDE4A10 and PDE4A11 (1:1,000 for each) 47, 48 or a-tubulin (1:5,000, mouse) (Sigma-Aldrich) were added in 1% marvel/TBST and incubated at 4 uC overnight. The membranes were washed 3 times for 10 min in TBST. Peroxidase-conjugated anti-rabbit (Sigma-Aldrich) or anti-mouse (GE Healthcare UK Ltd) were added 1:2,000 in 1% marvel/TBST and incubated for 1 h at room temperature. Membranes were washed as before, then incubated in Pierce ECL Western Blotting Substrate (Thermo Scientific) for 30 s and the signal was detected using film (Kodak, Carestream Health, Inc.). Densitometry was performed using Quantity One software (BioRad Laboratories).
For phosphorylated-CREB immunohistochemistry, mice were anaesthetized with isoflurane and perfused with PBS followed by 4% paraformaldehyde in PBS. Fixed brains were dissected and then cryoprotected in 30% sucrose in PBS overnight at 4 uC. Brains were mounted on cryostat chucks using OCT. Coronal sections were cut at a thickness of 25 mm and stored in PBS with 0.1% sodium azide. After rinsing in PBS (33) , incubation in 0.3% H 2 O 2 (30 min), and rinsing again in PBS (33) , sections were preincubated in 5% normal goat serum (Jackson ImmunoResearch Laboratories) in PBS for 20 min at room temperature. After preincubation, sections were incubated with rabbit-anti-pCREB IgG (1:1,500; Upstate Cell Signaling Solutions) in 1% normal goat serum, 0.3% Triton X-100 and 0.1% azide in PBS at room temperature for 24 h. Sections were then rinsed in PBS (33) and incubated for 3 h with biotinylated goat-anti-rabbit IgG (1:500; Jackson ImmunoResearch Laboratories) in PBS containing 0.3% Triton X-100 and 1% normal goat serum at 5 uC. After rinsing with PBS (33), sections were incubated with the avidin-biotinhorseradish peroxidase complex (1:500 ABC kit, Vector Laboratories) in PBS containing 0.3% Triton X-100 for 2 h at room temperature. Finally, after rinsing in PBS for 6 h, sections were processed with diaminobenzidine (0.02% in Tris-HCl, pH 7.6) with 100 ml 0.1% H 2 O 2 as a reaction initiator. After 7 min, the reaction was terminated by washing the sections with PBS. Sections were mounted with gelatin (0.7%) and dried for 24 h. The mounted sections were then dehydrated using ethanol and xylene, coverslipped with DPX (Merck), and dried for 24 h. Relative optical densities of pCREB immunoreactivity were quantified in subregions of the dorsal hippocampus (three sections per animal, averaged for both hemispheres) and in the amygdala (3-8 amygdalae) using ImageJ image analysis software. The optical density is expressed in arbitrary units corresponding to grey levels. The optical density values for each region were normalized to the background labelling within the same region to normalize for variability in staining between sections.
For corticosterone assays, animals were killed by cervical dislocation in control mice or mice that had been sleep-deprived for 5 h, and trunk blood was collected. After 30-60 min at room temperature, samples were centrifuged at 2,300g for 10 min to isolate the supernatant (plasma), which was then stored at 280 uC until enough samples had been accumulated to run the assay. Corticosterone concentrations were measured using a commercial [ 125 I]-radioimmunoassay kit (MP Biomedicals) according to instructions. Samples were run in duplicate. The minimum detection limit of the assay was 7.7 ng ml 21 and the inter-replicate variability was 6.0%. Gene expression analysis. For quantitative real-time PCR with reverse transcription (RT-PCR) experiments, mice were handled and sleep-deprived as described earlier. Hippocampal dissections were performed immediately after the deprivation, and alternated between SD and NSD animals. RNA preparation and real-time RT-PCR was performed as previously described 32 . In brief, hippocampi were flash-frozen in 500 ml RNAlater (Ambion) on dry ice and stored at 280 uC. Aerosol Barrier ART tips, DEPC-treated sterile water (Ambion), and autoclaved 1.5-ml microcentrifuge tubes were used for all subsequent steps. Thawed hippocampi were homogenized on ice in 1 ml Trizol (Invitrogen) using a dounce homogenizer. Phenol-chloroform (300 ml) addition was followed by vigorous mixing and room-temperature incubation for 3 min. Samples were transferred to phaselock gel tubes (Eppendorf) and centrifuged at 4 uC and full speed for 15 min to extract RNA. The aqueous phase was transferred to new tubes, where 2 volumes ethanol, 1/10 volume 3 M sodium acetate, and 1 ml glycogen (10 mg ml 21 ) were added. After gentle mixing, the samples were incubated at 220 uC for 10 min. Centrifugation at 4 uC and full speed was followed by aspiration of the supernatant. Pellets were washed with 300 ml 70% ethanol, and then centrifuged at 4 uC and full speed for 5 min. The supernatant was aspirated and samples were air-dried for approximately 10 min. After resuspension in 100 ml water, RNA was purified using the RNeasy system (Qiagen) according to the manufacturer's protocol. Residual DNA was removed by treatment with DNA-free (Ambion). RNA was then re-precipitated with 1 ml glycogen, 50 ml ammonium acetate and 250 ml ethanol. The pellet was then rinsed twice with 300 ml 80% ethanol, and resuspended in 24 ml RNase-free water. RNA concentration and purity was quantified by NanoDrop spectrophotometry (Thermo Fisher Scientific).
Generation of cDNA was carried out using the RETROscript kit (Ambion). Each reaction was performed with 1 mg RNA in a total volume of 20 ml composed as follows: 50 mM Tris-HCl, pH 8.3, 75 mM KCl, 3 mM MgCl 2 , 5 mM dithiothreitol (DTT), 500 mM each dNTP, 5 mM random decamers, 10 units RNase inhibitor and 100 units MMLV-RT. As controls, further reaction mixtures were generated that lacked either reverse transcriptase or template mRNA. Subsequent reactions were allowed to proceed at 44 uC for 1 h, followed by heat-inactivation at 100 uC for 10 min.
For quantitative real-time RT-PCR, reactions were prepared in 96-well optical reaction plates (ABI) with optical adhesive covers (ABI). Each well contained 11.4 ml cDNA, 1 ml of 5 mM primer mix solution and 12.4 ml Power SYBR Green PCR Master Mix (ABI). Three technical replicates were used. Reactions were carried out in the ABI Prism 7000 with an initial activation at 50 uC for 2 min followed by incubation at 95 uC for 15 min, and 40 subsequent cycles of 95 uC for 15 s, 56 uC for 30 s, and 72 uC for 30 s. Primer sequences were as follows: Pde4a: forward 59-CACCTTCCTGCTGCTTCTCT-39, reverse 59-CTGCTGGAAGG GTCTCTGTC-39. Pde4b: forward 59-CAGATCAGGGAACCAGGTGT-39, reverse 59-AGCGTGAGATGCTTGTGTTG-39. Pde4d: forward 59-AGATGAGT CGGTCTGGCAAC-39, reverse 59-CGGCCTTTTCTTCTTCTCCT-39. Data was normalized to Actg1, Hprt and Tuba4a before calculation of differences. Housekeeping primers were the same as described previously 32 . Relative quantification of gene expression was performed according to ABI's User Bulletin no.2. Fold change was calculated from the DC t values with corrections for standard curve data from each gene and housekeeping gene expression levels for each sample based on the relative standard curve method described in the Applied Biosystems manual. For each sample, the DC t was calculated against the mean for that gene's sample set. Next, each of these DC t values was corrected with the slope of the standard curve for the relevant primer set to account for any variation in primer amplification efficiency. The efficiency-corrected DC t value was normalized to the similarly corrected DC t from housekeeping genes for each sample to account for variability in mRNA input. The difference between corrected DC t for each sample was then grouped according to the type (SD or NSD) and the average DC t was calculated. Because C t values are on a logarithmic scale, fold change is equal to two raised to the difference between experimental and control DC t values. Because corrections were made for primer efficiency, we have presented the data as fold change. The data presented is the calculated mean for the biological replicates with n being equal to the number of biological replicates (that is, the number of mice examined). Statistics. For LTP experiments, the maintenance of LTP was analysed using repeated measures one-way analysis of variance (ANOVA) tests with Tukey post-hoc tests, with group and time as factors, and the percentage baseline fEPSP slope during the last 20 min of the recording as the variable. For experiments using rolipram treatment, repeated measures two-way ANOVA tests were used, with group and treatment as factors. Analysis of LTP induction was carried out using t-tests, except in the case of experiments using rolipram, in which twoway ANOVAs were used, with group and treatment as factors. To evaluate differences in input-output characteristics, a t-test was performed comparing the average linear regression slopes for sleep-deprived and control mice. For paired-pulse facilitation, a repeated measures two-way ANOVA with Tukey post-hoc tests was used with group and inter-stimulus interval as factors and the ratio of the initial fEPSP slopes elicited by the two stimuli as the variable. For whole-cell patch-clamp recordings, NMDA-receptor I-V curves were analysed using a two-way ANOVA with voltage and sleep deprivation as factors. NMDAreceptor input-output curves were compared using a two-way ANOVA with stimulation intensity and sleep deprivation as factors. NMDA receptor/AMPA receptor ratios were compared between sleep-deprived and non-sleep-deprived animals using a t-test. For cAMP assays, a non-parametric Kruskal-Wallis test was used because data across treatment groups was non-normal. An overall effect of group was found (H (5, N 5 108) 5 42.04, P , 0.0001), and P values reported in the text are from post-hoc Mann-Whitney U tests used to make the following planned comparisons: NSD control versus SD control, NSD 1 FSK versus SD 1 FSK, and NSD 1 FSK/IBMX versus SD 1 FSK/IBMX. For PDE activity assays and PDE4 western blots, t-tests were used to compare values between SD and NSD animals, using one-tailed P values because of our prediction that PDE levels and activity would be increased by sleep deprivation. For pCREB immunohistochemistry, t-tests were used to compare optical densities in each hippocampal region, using one-tailed P values because of our initial prediction that CREB phosphorylation would be reduced by sleep deprivation. For quantitative realtime RT-PCR experiments, t-tests were used to compare fold change values for each gene between sleep-deprived and control mice, and one-tailed P values are reported because of our initial prediction that PDE expression would be increased by sleep deprivation. Two-tailed P values are reported for RT-PCR experiments examining the effects of recovery sleep. For fear conditioning experiments, a two-way repeated measures ANOVA with Tukey post-hoc tests was used, with group (SD versus NSD) and drug treatment (rolipram versus vehicle) as factors, and context (trained, altered) as the repeated measure, and percentage freezing as the variable. Effects on context-specific freezing were measured using a two-way ANOVA with Tukey post-hoc tests, with group and drug treatment as factors, and the difference in percentage freezing between the trained and altered contexts as the variable. All statistics were carried out using Statistica 7 (Statsoft, Inc.). In all figures in the main text, asterisk represents a comparison with P , 0.05, and all error bars indicate 6 s.e.m.
